skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Peter, my two real estate companies in my portfolio are CIG and FSV and I want to rebalance down to 10 or 12%. I have read your recent comments about these companies and would like your opinion as to what two or three real estate companies you would use in a balanced portfolio. I am thinking of selling both and buying some stocks with more upside.

Thanks, Stephen
Read Answer Asked by stephen on October 29, 2015
Q: Hi team, I recently sold MCD (in an RRSP) after the run up, and am looking to redeploy cash into a blue chip healthcare or pharma stock in the US. I'm looking for reliable dividends with capital appreciation, and planning to hold for three plus years. MRK and PFE are looking like good candidates, do you have any favourite blue chip healthcare stocks that you think would be a better fit?
Thanks, Alex
Read Answer Asked by Alexander on October 29, 2015
Q: Until recently I had no healthcare exposure. My plan is to add about 4 positions in the US large cap healthcare/bio space. So far I have purchased JNJ and GILD. Can you suggest 2 or 3 other names? Based on the research reports I have read I am leaning toward CELG and AGN, but I'd appreciate your opinion. Thank-you.
Read Answer Asked by Albert on October 29, 2015
Q: I am thinking about investing in 1/3 BIP.UN, 1/3 BPY.UN and 1/3 BEP.UN but I am starting to wonder why I wouldn't just invest in the parent BAM.A if I was to do this. Obviously the dividend of the parent is lower than the three individual spin offs. Do you think that the overall return of BAM.A is the same as the spinoffs generally and is it just an issue of do you want internal share price growth or do you want more as a dividend? Or is the parent somehow inherently slower growing than the spinoffs for some reason? Thx!
Read Answer Asked by Michael on October 29, 2015
Q: I have $1,000,000 I want to invest in VFV & VCE and I am wondering what time frame is best to make the investments. Should it be over a 1 month or several months, tax loss selling etc. Would you have any recommendation? Thanks for your great service. Bill
Read Answer Asked by William J on October 28, 2015
Q: This is a utility and I've heard from some notable investors that this company's management is good at capital allocation. Looking at the past 4 years they are aggressively bought back shares and refinanced their debt. However, at some point earlier this year this company's stock took a nosedive. Can you share with us your opinion on this stock and if this is a good buy?
Read Answer Asked by Eugene on October 28, 2015
Q: My thinking around the recent shorting and possible near in the future shorts in the next, say month or so, is "Bring them on!"

I say this because if the companies are sound companies, then they will continue to be good holdings going forward. Nothing has changed regarding the actual companies. So these short term share price drops are Excellent opportunities to buy a new stock from one's watch list or to add some more shares to an existing holding. Or nice opportunities for some shorter term trading, such as over a few weeks are being presented.


As far as VRX is concerned over my years I have noticed that on the TSX when a company grows very rapidly and becomes the biggest on the TSX that it shortly afterwards will get knocked down in price significantly. There will be different reasons for each specific stock but it happens. The reason's may be fact based or not fact based, it does not matter. The important part is that it will happen. Think Nortel.


Stan
Read Answer Asked by Stan on October 28, 2015
Q: I found this lengthy article on naked shorting that was written in June this year that describes what could be happening today to the Canadian bio_techs. Publish at your discretion.

http://smithonstocks.com/illegal-naked-short-selling-appears-to-lie-at-the-heart-of-an-extensive-stock-manipulation-scheme/
Read Answer Asked by Peter on October 28, 2015
Q: Can you tell me what the earnings expectations are for this company. thanks.
Read Answer Asked by wendy on October 28, 2015
Q: Bought bto shares at 1.60$ it seems to lag behind other gold stocks on up days and lead the way on down days. What's the deal here?
Read Answer Asked by Mark on October 28, 2015
Q: Hi 5i Research team,
Walgreen’s announced a 100% cash take-over Rite Aid at 9$. The competition Bureau will review the transaction (I am relatively optimistic based on the recent Staples/Office Depot merger; the larger size of CVS; and competition from everywhere else in the US market). The closing is forecasted in the second half of 2016. I am wondering what to do (hold / sell on strength? / sell on strength in 2016).
This investment is outside my RRSP/TFSA: meaning large taxable gain (with only a small capital loss earlier this year to net against). The Federal Liberal may change taxation on capital gains before the closing of the transaction. I am using margin in this account: I pay about 2.75% of interest on the full amount backing RAD shares. RAD.US is currently trading around 8$ early Wednesday morning: therefore there is still about 11% of return to be made by waiting. There is an “opportunity cost” to wait, that could also be an “opportunity profit” of not reinvesting before the Fed make its first interest hike and shake the financial markets. The exchange rate could/will change (difficult to forecast, but my anticipations are: US appreciate versus CAD following a US rate hike in early 2016 => so no hurry here). US funds from this transaction will be immediately converted into CAD cash in my account.
Two US lawyers firm lunched a recourse against the board for accepting an offer that is too low, therefore not in the best interest of the shareholders (is there potential upside here?). Is it possible that Walgreen’s rise its offer without a competing bid? Can you reasonably expect a competing bid? If yes, could you named some potential alternative buyers (Walgreen’s has long been the main potential suspect). And finally, there is always the risk of the transaction not closing.
Am I forgetting something? Based on this picture, what do you recommend? Thank you for your advice, Eric
Read Answer Asked by Eric on October 28, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!